35 filings
8-K
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
8-K
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
8-K
PNT
POINT Biopharma Global Inc.
14 Aug 23
POINT Biopharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
7:21am
8-K
PNT
POINT Biopharma Global Inc.
3 Aug 23
Changes in Registrant's Certifying Accountant
4:05pm
8-K
PNT
POINT Biopharma Global Inc.
13 Jun 23
Departure of Directors or Certain Officers
4:45pm
8-K
nxmx6zozv9n0
5 Jun 23
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
a48stmd
7 Feb 23
Entry into a Material Definitive Agreement
8:00am
8-K
ty46qrrx
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
8-K
vg1 kdiwbi
13 Sep 22
POINT Biopharma Announces Proposed Public Offering of Common Stock
4:12pm
8-K
3g5iq8
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
8-K
kl2ke5 woypa
6 Sep 22
POINT Biopharma Announces Poster Presentation at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial
8:11am
8-K
z7dltefqyjha
3 Jun 22
Submission of Matters to a Vote of Security Holders
1:21pm
8-K
m6jxjce01hd
16 May 22
Other Events
8:20am
8-K
n9sczpq712jwhhw8egf5
12 May 22
Entry into a Material Definitive Agreement
8:42am
8-K
t23px
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am
8-K
dn89dnib6y62outhp1pl
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
4gg7am9zt 84
15 Feb 22
Other Events
4:15pm
8-K
lvmkqz2pfs3d1
10 Dec 21
Departure of Directors or Certain Officers
8:17am
8-K
g7g83y
1 Dec 21
Departure of Directors or Certain Officers
8:14am
8-K
4r0kb4 7xsobw
19 Nov 21
Regulation FD Disclosure
8:09am